Refresh

Nagarjuna Drugs Ltd. - Research Center

530064 NAGDRUG Group (XD) BSE data
Back to Company

Results

Statement

More

Balance Sheet
(Rs crore)
Mar ' 00
Sources of funds
Owner's fund

Equity share capital

5.24

Share application money

-

Preference share capital

-

Reserves & surplus

-5.76
Loan funds

Secured loans

3.47

Unsecured loans

1.54

Total

4.50
Uses of funds
Fixed assets

Gross block

4.32

Less : revaluation reserve

-

Less : accumulated depreciation

1.15

Net block

3.18

Capital work-in-progress

0.12

Investments

-
Net current assets

Current assets, loans & advances

1.45

Less : current liabilities & provisions

0.62

Total net current assets

0.83

Miscellaneous expenses not written

0.37

Total

4.50
Notes:

Book value of unquoted investments

-

Market value of quoted investments

-

Contingent liabilities

4.50

Number of equity sharesoutstanding (Lacs)

52.44
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com